Advancing IgAN Care: Expert Strategies for Transformative Patient Outcomes
Jurgen Floege MD
Uyen Huynh-Do, MD
Call to Action: Utilizing Avacopan to Improve AAV Care
Stephen McAdoo, MD
Overcoming Clinical Inertia in Hyperkalemia Management
Peter Rossing, DMSc, MD
Michael Böhm, MD, FESC
Luca De Nicola, MD, PhD
Curbside Consult: Optimizing IgAN Management
Khalil El Karoui, MD
Federico Alberici, MD, PhD
Incorporación de terapias dirigidas en la planificación del tratamiento de la VAA
David Jayne, MD
Bernhard Hellmich, MD
Understanding the Recent Advances in IgAN
Jürgen Floege, MD
Jonathan Barratt, PhD
Call to Action: Elevating CKD-aP Care
Carol Pollock, AO, MBBS, PhD, FRACP, FAHMS
Incorporating Targeted Therapies in Treatment Planning for AAV
A Multidisciplinary Approach to Managing Potassium Levels in Patients with Heart Failure When Optimizing RAASi Therapy in Complex Cases
Antoni Bayés-Genís, MD, PhD, FESC, FHFA
Patrick Rossignol, MD, PhD
What You Should Know About Managing Your Patients with Both CKD and Hyperkalemia
Ellie Kelepouris, MD, FACP, FAHA
Stephen J. Greene, MD, FACC, FHFSA
Achieving Success in IgAN & FSGS
Siân Griffin, MD, PhD
Loreto Gesualdo, MD, FERA
Achieving Success in IgAN & FSGS: Expert Insights on Current and Future Therapies
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
Thilo Krüger, MD, PhD
Steven Fishbane, MD
Lucio Manenti, MD, PhD
Separating Fact from Fiction: The Realities of CKD-aP
Antoine Lanot, MD, PhD
Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
Mario Cozzolino, MD, PhD
Jan T. Kielstein, MD, FASN, FERA
Case-Based Management of AAV
Annette Bruchfeld, MD, PhD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We’re glad to see you’re enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.